Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase

Background: Evidence on whether the influenza vaccine could exacerbate immune-related adverse events, including myopericarditis (MP), in patients treated with immune checkpoint inhibitors (ICIs), is still conflicting. We explored this issue through a global real-world approach. Methods: We queried t...

Descripción completa

Detalles Bibliográficos
Autores principales: Gatti, Milo, Raschi, Emanuel, Moretti, Ugo, Ardizzoni, Andrea, Poluzzi, Elisabetta, Diemberger, Igor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823897/
https://www.ncbi.nlm.nih.gov/pubmed/33406694
http://dx.doi.org/10.3390/vaccines9010019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823897/
https://www.ncbi.nlm.nih.gov/pubmed/33406694
http://dx.doi.org/10.3390/vaccines9010019

Ejemplares similares